世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ウェアラブル非侵襲血糖モニタリングデバイスの世界市場成長2023-2029年


Global Wearable Non-invasive Blood Glucose Monitoring Device Market Growth 2023-2029

弊社(LP Info Research)の最新調査によると、ウェアラブル非侵襲血糖モニタリングデバイスの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年8月2日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
110 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

弊社(LP Info Research)の最新調査によると、ウェアラブル非侵襲血糖モニタリングデバイスの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、ウェアラブル非侵襲血糖モニタリングデバイスは、レビュー期間中のCAGR %で2029年までに百万米ドルの再調整された規模になると予測されています。
この調査レポートは、世界のウェアラブル非侵襲血糖モニタリングデバイス市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、ウェアラブル非侵襲血糖モニタリングデバイスは今後の市場で安定した成長を示すと予想される。しかし、ウェアラブル非侵襲血糖モニタリングデバイスの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場プレイヤーは、ウェアラブル非侵襲血糖モニタリングデバイス市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。
ウェアラブル非侵襲性血糖モニタリング・デバイスは、皮膚を刺して血液サンプルを採取するような侵襲的な処置を必要とせずに、個人の血糖値を測定するように設計されたウェアラブル技術の一種である。この種の装置は通常、光学センサー、電磁センサー、熱センサーなどの非侵襲的技術を使用して、血糖値をリアルタイムで測定する。この装置は通常、手首など身体に装着して使用し、血糖値の継続的な監視が可能であるため、糖尿病患者など、病状を管理するために定期的に血糖値を監視する必要がある場合に特に有用である。
主な特徴
ウェアラブル非侵襲血糖モニタリングデバイス市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス市場の現在の規模と成長の概要を提供します。過去データ、タイプ別(連続型、間欠型など)の市場区分、地域別内訳などが含まれる場合があります。
市場促進要因と課題:当レポートでは、政府規制、環境問題、技術進歩、消費者嗜好の変化など、ウェアラブル非侵襲血糖測定器市場の成長を促進する要因を特定・分析することができます。また、インフラの制限、航続距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、ウェアラブル非侵襲型血糖モニタリングデバイス市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業や市場に与える潜在的な影響にもスポットを当てています。
技術開発:この調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス産業における最新の技術開発を掘り下げることができます。これには、ウェアラブル非侵襲性血糖モニタリングデバイス技術の進歩、ウェアラブル非侵襲性血糖モニタリングデバイスの新規参入企業、ウェアラブル非侵襲性血糖モニタリングデバイスの新規投資、ウェアラブル非侵襲性血糖モニタリングデバイスの将来を形作るその他の技術革新などが含まれます。
川下の事業者の好み:このレポートは、ウェアラブル非侵襲性血糖モニタリングデバイス市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買決定、ウェアラブル非侵襲血糖モニタリングデバイス製品の嗜好に影響を与える要因が含まれています。
政府の政策とインセンティブこの調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、ウェアラブル非侵襲血糖モニタリングデバイス市場の促進を目的としたその他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性当調査レポートでは、ウェアラブル非侵襲血糖モニタリングデバイス市場の環境への影響と持続可能性の側面を評価しています。
市場予測と将来展望:当調査レポートでは、実施した分析に基づいて、ウェアラブル非侵襲血糖モニタリングデバイス産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、ウェアラブル非侵襲血糖モニタリングデバイス市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
ウェアラブル非侵襲血糖モニタリングデバイス市場は、タイプ別と用途別に分けられる。2018-2029年の期間について、セグメント間の成長は、タイプ別、アプリケーション別の消費額について、数量と金額で正確な計算と予測を提供します。
タイプ別セグメント
連続的
断続的
用途別セグメント
スポーツ&エンターテインメント
医療
医療研究
その他
本レポートでは、市場を地域別にも分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ノウ・ラボ
グラフウェア
ADI
クォンタム・オペレーション
ダイヤモンテック
ハガーテック
ライフプラス
アフォンテクノロジー
アボット
デックスコム
クノーガ・メディカル
インテグリティ・アプリケーション
台湾バイオフォトニック
メディワイズ
グライセンス社
グルコワイズ
NXP
アップル
ファーウェイ
本レポートで扱う主な質問
ウェアラブル非侵襲血糖モニタリングデバイスの世界市場の10年展望は?
ウェアラブル非侵襲血糖モニタリングデバイスの世界市場および地域別市場成長を促進する要因は何か?
市場別・地域別で最も急成長するのはどの技術か?
ウェアラブル非侵襲血糖モニタリングデバイスの市場機会は最終市場規模によってどのように異なるのか?
ウェアラブル非侵襲血糖モニタリングデバイスのタイプ別、用途別内訳は?
COVID-19とロシア・ウクライナ戦争の影響は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Country/Region, 2018, 2022 & 2029
2.2 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Type
2.2.1 Continuous
2.2.2 Intermittent
2.3 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
2.3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Type (2018-2023)
2.3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Type (2018-2023)
2.4 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Application
2.4.1 Sports & Entertainment
2.4.2 Medical
2.4.3 Medical Research
2.4.4 Others
2.5 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
2.5.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Market Share by Application (2018-2023)
2.5.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Application (2018-2023)
3 Global Wearable Non-invasive Blood Glucose Monitoring Device by Company
3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Breakdown Data by Company
3.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Company (2018-2023)
3.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Company (2018-2023)
3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Company (2018-2023)
3.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Company (2018-2023)
3.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue Market Share by Company (2018-2023)
3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Company
3.4 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Product Location Distribution
3.4.2 Players Wearable Non-invasive Blood Glucose Monitoring Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region
4.1 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Country/Region (2018-2023)
4.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.4 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.5 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.6 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
5 Americas
5.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country
5.1.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
5.1.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
5.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
5.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region
6.1.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region (2018-2023)
6.1.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Region (2018-2023)
6.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
6.3 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device by Country
7.1.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
7.1.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
7.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
7.3 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device by Country
8.1.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
8.3 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wearable Non-invasive Blood Glucose Monitoring Device
10.3 Manufacturing Process Analysis of Wearable Non-invasive Blood Glucose Monitoring Device
10.4 Industry Chain Structure of Wearable Non-invasive Blood Glucose Monitoring Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wearable Non-invasive Blood Glucose Monitoring Device Distributors
11.3 Wearable Non-invasive Blood Glucose Monitoring Device Customer
12 World Forecast Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region
12.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Market Size Forecast by Region
12.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Region (2024-2029)
12.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Type
12.7 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Application
13 Key Players Analysis
13.1 Know Labs
13.1.1 Know Labs Company Information
13.1.2 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.1.3 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Know Labs Main Business Overview
13.1.5 Know Labs Latest Developments
13.2 GraphWear
13.2.1 GraphWear Company Information
13.2.2 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.2.3 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GraphWear Main Business Overview
13.2.5 GraphWear Latest Developments
13.3 ADI
13.3.1 ADI Company Information
13.3.2 ADI Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.3.3 ADI Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ADI Main Business Overview
13.3.5 ADI Latest Developments
13.4 Quantum Operation
13.4.1 Quantum Operation Company Information
13.4.2 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.4.3 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Quantum Operation Main Business Overview
13.4.5 Quantum Operation Latest Developments
13.5 DiaMonTech
13.5.1 DiaMonTech Company Information
13.5.2 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.5.3 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 DiaMonTech Main Business Overview
13.5.5 DiaMonTech Latest Developments
13.6 Hagar Tech
13.6.1 Hagar Tech Company Information
13.6.2 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.6.3 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hagar Tech Main Business Overview
13.6.5 Hagar Tech Latest Developments
13.7 LifePlus
13.7.1 LifePlus Company Information
13.7.2 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.7.3 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LifePlus Main Business Overview
13.7.5 LifePlus Latest Developments
13.8 Afon Technology
13.8.1 Afon Technology Company Information
13.8.2 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.8.3 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Afon Technology Main Business Overview
13.8.5 Afon Technology Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.9.3 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 DexCom
13.10.1 DexCom Company Information
13.10.2 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.10.3 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 DexCom Main Business Overview
13.10.5 DexCom Latest Developments
13.11 Cnoga Medical
13.11.1 Cnoga Medical Company Information
13.11.2 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.11.3 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cnoga Medical Main Business Overview
13.11.5 Cnoga Medical Latest Developments
13.12 Integrity Applications
13.12.1 Integrity Applications Company Information
13.12.2 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.12.3 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Integrity Applications Main Business Overview
13.12.5 Integrity Applications Latest Developments
13.13 Taiwan Biophotonic
13.13.1 Taiwan Biophotonic Company Information
13.13.2 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.13.3 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Taiwan Biophotonic Main Business Overview
13.13.5 Taiwan Biophotonic Latest Developments
13.14 MediWise
13.14.1 MediWise Company Information
13.14.2 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.14.3 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 MediWise Main Business Overview
13.14.5 MediWise Latest Developments
13.15 GlySens Incorporated
13.15.1 GlySens Incorporated Company Information
13.15.2 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.15.3 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 GlySens Incorporated Main Business Overview
13.15.5 GlySens Incorporated Latest Developments
13.16 GlucoWise
13.16.1 GlucoWise Company Information
13.16.2 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.16.3 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 GlucoWise Main Business Overview
13.16.5 GlucoWise Latest Developments
13.17 NXP
13.17.1 NXP Company Information
13.17.2 NXP Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.17.3 NXP Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 NXP Main Business Overview
13.17.5 NXP Latest Developments
13.18 Apple
13.18.1 Apple Company Information
13.18.2 Apple Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.18.3 Apple Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Apple Main Business Overview
13.18.5 Apple Latest Developments
13.19 Huawei
13.19.1 Huawei Company Information
13.19.2 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.19.3 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Huawei Main Business Overview
13.19.5 Huawei Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our (LP Info Research) latest study, the global Wearable Non-invasive Blood Glucose Monitoring Device market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Wearable Non-invasive Blood Glucose Monitoring Device is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Wearable Non-invasive Blood Glucose Monitoring Device market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Wearable Non-invasive Blood Glucose Monitoring Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Wearable Non-invasive Blood Glucose Monitoring Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Wearable Non-invasive Blood Glucose Monitoring Device market.
A wearable non-invasive blood glucose monitoring device is a type of wearable technology that is designed to measure blood glucose levels in individuals without the need for invasive procedures such as pricking the skin to obtain blood samples. This type of device typically uses non-invasive techniques such as optical sensors, electromagnetic sensors, or thermal sensors to measure blood glucose levels in real-time. The device is usually worn on the body, such as on the wrist, and can provide continuous monitoring of blood glucose levels, which is particularly useful for individuals with diabetes who need to monitor their glucose levels regularly to manage their condition.
Key Features:
The report on Wearable Non-invasive Blood Glucose Monitoring Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Wearable Non-invasive Blood Glucose Monitoring Device market. It may include historical data, market segmentation by Type (e.g., Continuous, Intermittent), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Wearable Non-invasive Blood Glucose Monitoring Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Wearable Non-invasive Blood Glucose Monitoring Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Wearable Non-invasive Blood Glucose Monitoring Device industry. This include advancements in Wearable Non-invasive Blood Glucose Monitoring Device technology, Wearable Non-invasive Blood Glucose Monitoring Device new entrants, Wearable Non-invasive Blood Glucose Monitoring Device new investment, and other innovations that are shaping the future of Wearable Non-invasive Blood Glucose Monitoring Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Wearable Non-invasive Blood Glucose Monitoring Device market. It includes factors influencing customer ' purchasing decisions, preferences for Wearable Non-invasive Blood Glucose Monitoring Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Wearable Non-invasive Blood Glucose Monitoring Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Wearable Non-invasive Blood Glucose Monitoring Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Wearable Non-invasive Blood Glucose Monitoring Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Wearable Non-invasive Blood Glucose Monitoring Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Wearable Non-invasive Blood Glucose Monitoring Device market.
Market Segmentation:
Wearable Non-invasive Blood Glucose Monitoring Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Continuous
Intermittent
Segmentation by application
Sports & Entertainment
Medical
Medical Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Know Labs
GraphWear
ADI
Quantum Operation
DiaMonTech
Hagar Tech
LifePlus
Afon Technology
Abbott
DexCom
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated
GlucoWise
NXP
Apple
Huawei
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wearable Non-invasive Blood Glucose Monitoring Device market?
What factors are driving Wearable Non-invasive Blood Glucose Monitoring Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wearable Non-invasive Blood Glucose Monitoring Device market opportunities vary by end market size?
How does Wearable Non-invasive Blood Glucose Monitoring Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Country/Region, 2018, 2022 & 2029
2.2 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Type
2.2.1 Continuous
2.2.2 Intermittent
2.3 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
2.3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Type (2018-2023)
2.3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Type (2018-2023)
2.4 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Application
2.4.1 Sports & Entertainment
2.4.2 Medical
2.4.3 Medical Research
2.4.4 Others
2.5 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
2.5.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Market Share by Application (2018-2023)
2.5.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Application (2018-2023)
3 Global Wearable Non-invasive Blood Glucose Monitoring Device by Company
3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Breakdown Data by Company
3.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Company (2018-2023)
3.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Company (2018-2023)
3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Company (2018-2023)
3.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Company (2018-2023)
3.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue Market Share by Company (2018-2023)
3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Company
3.4 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Product Location Distribution
3.4.2 Players Wearable Non-invasive Blood Glucose Monitoring Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region
4.1 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Country/Region (2018-2023)
4.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.4 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.5 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
4.6 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth
5 Americas
5.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country
5.1.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
5.1.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
5.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
5.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region
6.1.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region (2018-2023)
6.1.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Region (2018-2023)
6.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
6.3 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device by Country
7.1.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
7.1.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
7.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
7.3 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device by Country
8.1.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type
8.3 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wearable Non-invasive Blood Glucose Monitoring Device
10.3 Manufacturing Process Analysis of Wearable Non-invasive Blood Glucose Monitoring Device
10.4 Industry Chain Structure of Wearable Non-invasive Blood Glucose Monitoring Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wearable Non-invasive Blood Glucose Monitoring Device Distributors
11.3 Wearable Non-invasive Blood Glucose Monitoring Device Customer
12 World Forecast Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region
12.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Market Size Forecast by Region
12.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Region (2024-2029)
12.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Type
12.7 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Application
13 Key Players Analysis
13.1 Know Labs
13.1.1 Know Labs Company Information
13.1.2 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.1.3 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Know Labs Main Business Overview
13.1.5 Know Labs Latest Developments
13.2 GraphWear
13.2.1 GraphWear Company Information
13.2.2 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.2.3 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GraphWear Main Business Overview
13.2.5 GraphWear Latest Developments
13.3 ADI
13.3.1 ADI Company Information
13.3.2 ADI Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.3.3 ADI Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ADI Main Business Overview
13.3.5 ADI Latest Developments
13.4 Quantum Operation
13.4.1 Quantum Operation Company Information
13.4.2 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.4.3 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Quantum Operation Main Business Overview
13.4.5 Quantum Operation Latest Developments
13.5 DiaMonTech
13.5.1 DiaMonTech Company Information
13.5.2 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.5.3 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 DiaMonTech Main Business Overview
13.5.5 DiaMonTech Latest Developments
13.6 Hagar Tech
13.6.1 Hagar Tech Company Information
13.6.2 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.6.3 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hagar Tech Main Business Overview
13.6.5 Hagar Tech Latest Developments
13.7 LifePlus
13.7.1 LifePlus Company Information
13.7.2 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.7.3 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LifePlus Main Business Overview
13.7.5 LifePlus Latest Developments
13.8 Afon Technology
13.8.1 Afon Technology Company Information
13.8.2 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.8.3 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Afon Technology Main Business Overview
13.8.5 Afon Technology Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.9.3 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 DexCom
13.10.1 DexCom Company Information
13.10.2 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.10.3 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 DexCom Main Business Overview
13.10.5 DexCom Latest Developments
13.11 Cnoga Medical
13.11.1 Cnoga Medical Company Information
13.11.2 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.11.3 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cnoga Medical Main Business Overview
13.11.5 Cnoga Medical Latest Developments
13.12 Integrity Applications
13.12.1 Integrity Applications Company Information
13.12.2 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.12.3 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Integrity Applications Main Business Overview
13.12.5 Integrity Applications Latest Developments
13.13 Taiwan Biophotonic
13.13.1 Taiwan Biophotonic Company Information
13.13.2 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.13.3 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Taiwan Biophotonic Main Business Overview
13.13.5 Taiwan Biophotonic Latest Developments
13.14 MediWise
13.14.1 MediWise Company Information
13.14.2 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.14.3 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 MediWise Main Business Overview
13.14.5 MediWise Latest Developments
13.15 GlySens Incorporated
13.15.1 GlySens Incorporated Company Information
13.15.2 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.15.3 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 GlySens Incorporated Main Business Overview
13.15.5 GlySens Incorporated Latest Developments
13.16 GlucoWise
13.16.1 GlucoWise Company Information
13.16.2 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.16.3 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 GlucoWise Main Business Overview
13.16.5 GlucoWise Latest Developments
13.17 NXP
13.17.1 NXP Company Information
13.17.2 NXP Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.17.3 NXP Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 NXP Main Business Overview
13.17.5 NXP Latest Developments
13.18 Apple
13.18.1 Apple Company Information
13.18.2 Apple Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.18.3 Apple Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Apple Main Business Overview
13.18.5 Apple Latest Developments
13.19 Huawei
13.19.1 Huawei Company Information
13.19.2 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications
13.19.3 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Huawei Main Business Overview
13.19.5 Huawei Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る